Abstract | BACKGROUND: METHODS: Pediatric patients diagnosed with CGD from a medical center in Taiwan were enrolled from January 1999 to Oct 2021. RESULTS: Nine pediatric patients with CGD were enrolled: six X-linked (XL) CGD with CYBB gene mutations, three autosomal recessive (AR) CGD with two NCF1 and one CYBA gene mutations. The median age of onset and age of diagnosis was 0.92 and 2.64 years, respectively. Patients with XL-CGD had a younger age of onset (4.6 months vs. 1.83 years, P = 0.06) and age of diagnosis (1.71 vs. 8.86 years, P = 0.024) than AR-CGD patients. The most common sites of infections were skin and soft tissue abscesses. The most common pathogens were Staphylococcus, Serratia, and Salmonella spp. Prophylactic antibiotics, anti-fungal agents, and interferon-gamma (IFN-γ) were given in 9 (100%), 7 (77.8%), and 8 (88.9%) patients, respectively. The mean duration of IFN-γ usage was 5.15 years. One male patient with XL-CGD was successfully treated with hematopoietic stem cell transplantation at 2.2 years. The mortality rate was 11.1%, and the estimated overall survival at 20 years was 66.7%. CONCLUSION: Staphylococcus aureus, Serratia marcescens, and Salmonella infections are important in Taiwanese CGD patients. Patients with XL-CGD have early disease onset. IFN-γ prophylaxis and prophylactic anti-microbial agents might have an effect on alleviating the infection episodes in CGD patients.
|
Authors | Ting-Sheng Lin, Jyh-Hong Lee, Li-Chieh Wang, Yao-Hsu Yang, Yu-Lung Lau, Wen-I Lee, Yu-Tsan Lin, Bor-Luen Chiang, Hsin-Hui Yu |
Journal | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
(J Microbiol Immunol Infect)
Vol. 56
Issue 1
Pg. 130-138
(Feb 2023)
ISSN: 1995-9133 [Electronic] England |
PMID | 35842407
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022. Published by Elsevier B.V. |
Chemical References |
|
Topics |
- Child
- Humans
- Male
- Infant
- Child, Preschool
- Granulomatous Disease, Chronic
(genetics, therapy, diagnosis)
- Taiwan
(epidemiology)
- Mutation
- Neutrophils
- Anti-Infective Agents
(therapeutic use)
|